FIELD: medicine.
SUBSTANCE: invention relates to the intraperitoneal injection of dihydrobromide 2-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a]benzimidazole as an antiproliferative and antimetastatic agent against Lewis lung epidermoid carcinoma.
EFFECT: invention provides antiproliferative and antimetastatic effects of dihydrobromide 2-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a]benzimidazole against Lewis lung epidermoid carcinoma when injected intraperitoneally.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-TUMOUR AGENT AGAINST LUNG TUMOUR | 2021 |
|
RU2765472C1 |
MEANS FOR INHIBITION OF METASTASIS IN LUNGS | 2016 |
|
RU2632703C1 |
METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2678769C2 |
PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
Authors
Dates
2023-03-17—Published
2022-01-19—Filed